In the News
Cervical cancer screening using the pap test remains critical for this preventable disease. In BC, provincial screening rates have remained the same over the last decade where approximately 30% of the population are under or never screened. Despite this, few interventions have been implemented to increase screening, where rates are lowest among priority populations who face barriers to clinic-based screening.
The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is a randomized, breast cancer screening trial that will help researchers learn about the best ways to find breast cancer in women who have no symptoms.
September 29th is World Heart Day. Check out our Q&A with Dr. Karen Tran on her research on hypertensive disorders in pregnant women!
In the Media
Dr. Gina Ogilvie is the lead study author on a publication in the Canadian Medical Association Journal about the sexual health practices of teen girls after the introduction of the HPV vaccine in BC public schools. The publication has been featured in the Vancouver Sun, Newsweek, and more!
Dr. Ogilvie and team featured in the media for new study on the use of HPV testing to screen for cervical cancer
Dr. Gina Ogilvie and team have been featured by multiple news outlets for their new publication in JAMA, Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Dr. Lori Brotto was featured on CTV’s Your Morning to talk about her book Better Sex Through Mindfulness. Check out the clip here.
There are no upcoming events.
Read the latest edition of the Women’s Health Research Institute’s eBlast, which includes news, research, events, and more.